Efficacy and Tolerability of Guanylate Cyclase-C Agonists for Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation: A Systematic Review and Meta-Analysis.

Author: KimHyungjin Myra, SchoenfeldPhilip, ShahEric D

Paper Details 
Original Abstract of the Article :
Linaclotide and plecanatide are guanylate cyclase-C (GCC) agonists for the treatment of chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS-C). Our objective is to evaluate the efficacy and tolerability of GCC agonists based on data from multiple randomized cont...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/29380823

データ提供:米国国立医学図書館(NLM)

Guanylate Cyclase-C Agonists for Constipation: A Promising Path Forward

Constipation is a common ailment, like a stubborn desert sandstorm that slows down the flow of things. This study focuses on guanylate cyclase-C (GCC) agonists, a type of medication used to treat irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC). The researchers conducted a systematic review and meta-analysis to evaluate the efficacy and tolerability of GCC agonists in managing these debilitating conditions.

GCC Agonists: A Potential Oasis in the Desert of Constipation

The study suggests that GCC agonists may offer a promising treatment option for IBS-C and CIC, potentially providing relief from the discomfort and inconvenience associated with these conditions. It's like discovering a new source of water in the desert, offering a chance for hydration and rejuvenation. The researchers found that these medications were generally effective and well-tolerated, providing hope for those seeking relief from constipation.

Navigating the Desert of Digestive Health

This study emphasizes the importance of personalized approaches to managing constipation, considering individual needs and preferences. It's like understanding the diverse terrain of the desert and choosing the best path for each traveler. By providing comprehensive information about GCC agonists, the researchers offer clinicians a valuable tool for managing constipation and improving patients' quality of life.

Dr.Camel's Conclusion

This systematic review highlights the potential of GCC agonists to provide relief for those struggling with IBS-C and CIC. Just like a camel caravan must find the right route to navigate the desert, clinicians must carefully consider individual factors when choosing the best treatment approach for constipation, ensuring a smooth and comfortable journey through the digestive system.
Date :
  1. Date Completed 2019-08-06
  2. Date Revised 2022-04-09
Further Info :

Pubmed ID

29380823

DOI: Digital Object Identifier

NIHMS1581938

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.